Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Visual impairment
Clinical narrative: light headed; vision went spotty; chest became heavy; tingling sensation over body; breathing labored; breathing labored and increased in rate; nausea; felt wave of hot come over me; I feel fatigued; very sore at the injection site; Booster; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Jan2022 15:00 (Batch/Lot number: unknown) at the age of 40 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: BABY ASPIRIN; ALLEGRA; PHENYLEPHRINE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown., Location of injection: Arm Right, Vaccine Administration Time: 06:00), administration date: 19Jan2021, when the patient was 39 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown., Location of injection: Arm Left, Vaccine Administration Time: 07:00), administration date: 23Dec2020, when the patient was 39 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 10Jan2022 15:00, outcome "unknown", described as "Booster"; DIZZINESS (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "light headed"; VISUAL IMPAIRMENT (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "vision went spotty"; CHEST DISCOMFORT (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "chest became heavy"; PARAESTHESIA (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "tingling sensation over body"; DYSPNOEA (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "breathing labored"; RESPIRATORY RATE INCREASED (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "breathing labored and increased in rate"; NAUSEA (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "nausea"; FEELING HOT (non-serious) with onset 11Jan2022 06:00, outcome "recovered" (11Jan2022), described as "felt wave of hot come over me"; FATIGUE (non-serious) with onset 11Jan2022 06:00, outcome "unknown", described as "I feel fatigued"; VACCINATION SITE PAIN (non-serious) with onset 11Jan2022 06:00, outcome "unknown", described as "very sore at the injection site". The events "booster", "light headed", "vision went spotty", "chest became heavy", "tingling sensation over body", "breathing labored", "breathing labored and increased in rate", "nausea", "felt wave of hot come over me", "i feel fatigued" and "very sore at the injection site" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of immunisation, dizziness, visual impairment, chest discomfort, paraesthesia, dyspnoea, respiratory rate increased, nausea, feeling hot, fatigue, vaccination site pain. Additional information: The patient had not been diagnosed with COVID prior to vaccination, had no known allergies and had not received other vaccines in four weeks. The patient reported after lying down these symptoms stopped but she felt fatigued and very sore at the injection site. The patient had a telehealth visit on 11Jan2022 and reported they might ask her to test for COVID. Since vaccination the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.